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Abstract
Background: Quantitative data are lacking on published malaria research. The purpose of the study is to
characterize trends in malaria-related literature from 1990 to 2009 in 11 Asian-Pacific countries that are committed
to malaria elimination as a national goal.
Methods: A systematic search was conducted for articles published from January 1990 to December 2009 in
PubMed/MEDLINE using terms for malaria and 11 target countries (Bhutan, China, North Korea, Indonesia, Malaysia,
Philippines, Solomon Islands, South Korea, Sri Lanka, Thailand and Vanuatu). The references were collated and
categorized according to subject, Plasmodium species, and whether they contained original or derivative data.
Results: 2,700 articles published between 1990 and 2009 related to malaria in the target countries. The annual
output of malaria-related papers increased linearly whereas the overall biomedical output from these countries
grew exponentially. The percentage of malaria-related publications was nearly 3% (111/3741) of all biomedical
publications in 1992 and decreased to less than 1% (118/12171; p < 0.001) in 2009. Thailand had the highest
absolute output of malaria-related papers (n = 1211), followed by China (n = 609) and Indonesia (n = 346).
Solomon Islands and Vanuatu had lower absolute numbers of publications, but both countries had the highest
number of publications per capita (1.3 and 2.5 papers/1,000 population). The largest percentage of papers
concerned the epidemiology and control of malaria (53%) followed by studies of drugs and drug resistance (47%).
There was an increase in the proportion of articles relating to epidemiology, entomology, biology, molecular
biology, pathophysiology and diagnostics from the first to the second decade, whereas the percentage of papers
on drugs, clinical aspects of malaria, immunology, and social sciences decreased.
Conclusions: The proportion of malaria-related publications out of the overall biomedical output from the 11
target Asian-Pacific countries is decreasing. The discovery and evaluation of new, safe and effective drugs and
vaccines is paramount. In addition the elimination of malaria will require operational research to implement and
scale up interventions.
Background
Research and development play a major role in many
enterprises. A typical ratio of research and development
for an industrial company is about 3.5% of revenues
while in some pharmaceutical companies this ratio may
be several-fold higher [1]. Although malaria control and
elimination is not an industrial enterprise, most experts
would agree that efforts supported by evidence and new
tools are more likely to be successful. Very little quanti-
tative data have been published to quantify the malaria
research effort particularly in the malaria endemic coun-
tries of Asia. The lack of knowledge of research outputs
reflects the intrinsic difficulties in quantifying these
measures. The number of publications is an indirect
measure of scientific research outputs and activities.
Although not all research results in a publication, there
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the research effort and funding opportunities.
There is uncertainty about what tools are needed and
how tools should be used in order to achieve elimina-
tion. In this context research and development will play
a pivotal role in shaping future malaria elimination
activities. Much can be learned from successful pro-
grammes, but the heterogeneity of the malaria epide-
miology between nations makes it essential to adapt
programmes to the current local needs. In 2009, 11
countries in the Asian Pacific region announced national
goals to eliminate malaria (Bhutan, China, North Korea,
Indonesia, Malaysia, Philippines, Solomon Islands, South
Korea, Sri Lanka, Thailand and Vanuatu), and together
established the Asian Pacific Malaria Elimination Net-
work (http://apmen.org/). To develop a better under-
standing of the malaria research outputs and activities
in these APMEN countries, the number of peer-
reviewed publications has been reviewed, with the pur-
pose of characterizing trends in malaria-related litera-
ture over the last two decades.
Methods
The target countries
The 11 APMEN countries have made significant progress
towards malaria elimination on a national or sub national
level, and have made an official commitment toward elimi-
nation. The population of the countries included in this
study varied greatly, ranging from 246,000 people in
Vanuatu to 1,381,796,000 in China (Table 1)[2]. Gross
domestic product (GDP) per capita varied from USD
16,700 in South Korea to USD 1,200 in the Solomon
Islands [2]. The population at risk of vivax malaria ranged
from 461,951,000 in China to 242,000 in Vanuatu [3]. The
largest population at risk of falciparum malaria was
132,878,000, found in Indonesia [4,5].
Criteria for considering articles for this review
Articles with an abstract in English language relating to
malaria in the 11 target countries within the time frame
of January 1990 to December 2009 were included in the
study. The search methods for acquiring article refer-
ences are described in supplementary materials (Addi-
tional files 1, 2 and 3).
Processing reference library
The publication type for each article was derived from
the PubMed/Medline database and articles were cate-
gorized as containing original data, or non-original, deri-
vative data or being irrelevant to malaria research based
on these publication types (see Additional file 2). Refer-
ences not provided with a publication type were manu-
ally tagged. Each paper was assigned to at least one of
the following subjects based on the keywords included
in the reference: Diagnostics, Molecular/Genetics, Clini-
cal, Entomology/Insecticides, Biology/Biochemistry,
Social Sciences/Health Policy, Epidemiology/Control,
Immunology/Vaccines, Pathophysiology, Drugs/Drug
resistance [6]. The search alg o r i t h mu s e dt oc a t e g o r i z e
the papers is shown in Additional file 3.
All papers were further classified as relating to Plas-
modium falciparum or P. vivax depending on whether
the term ‘falciparum’ or ‘vivax’ appeared in the title,
abstract or keywords. Malaria-related papers in which
the Plasmodium species was not defined were categor-
ized as “neither”. These papers were manually reviewed
to assess their relevance for malaria and excluded if they
were not sufficiently relevant. Articles were also
Table 1 Key demographic and economic data from the 11 APMEN countries
Population/
1000[2]
GDP [2]
(billion
USD)
GDP per capita [2]
(thousand USD)
Health Expenditure
per capita [14](USD)
HDI
[15]
PAR PF/
1000 [5]
PAR PV/
1000 [3]
reported Pf
cases 2009
[16]
reported Pv
cases 2009
[16]
Bhutan 723 1.3 1.8 49 0.62 411 481 559 413
China 1,381,796 4909.0 3.7 94 0.66 16,646 461,951 948 8,214
Indonesia 232,544 539.4 2.3 41.8 0.60 132,878 129,618 212,501 237,929
Korea
North
23,963 27.8 1.2 14 NA 0 22,079 0 14,845
Korea
South
48,517 832.5 16.7 1168 0.88 0 3,022 0 1,343
Malaysia 27,949 191.5 6.8 259 0.74 27,845 27,902 1,885 3,379
Philippines 93,617 161.0 1.7 52 0.64 50,154 50,339 13,933 4,951
Solomon
Islands
536 0.7 1.2 44 0.49 534 535 19,580 8,544
Sri Lanka 20,410 41.3 2.0 62 0.66 10,231 11,986 29 529
Thailand 68,141 263.9 3.9 136 0.65 40,839 41,966 9,486 13,616
Vanuatu 246 0.6 2.6 67 0.69 242 242 1,543 1,618
NA = not available, USD = United States Dollars, HDI = Human Development Index, PAR = population at risk, PF = Plasmodium falciparum,P V=Plasmodium vivax
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type field contained ‘clinical’ or ‘randomized controlled’.
The total number of overall biomedical publications
from the target countries were gathered by removing
the keywords for malaria (P. falciparum, P. vivax)f r o m
the search algorithm.
Statistics
Data were processed using Excel (Microsoft, WA, USA)
filters and Excel was also used to compute the correla-
tion coefficient r
2. Statistical comparisons were com-
puted with Statcalc (EpiInfo, version 6, Centers for
Disease Control and Prevention, Atlanta, USA). For
categorical variables, percentages and corresponding
95% confidence intervals (95% CI) were calculated using
Wilson’s method. Proportions were examined using c
2
with Yates’ correction.
Results
In total, 2,700 unique malaria-related, peer-reviewed
references published between 1990 and 2009 were iden-
tified as associated with the 11 target countries. Of
these papers 1,903 (70%) were articles containing origi-
nal data and 319 (12%) were articles containing deriva-
tive data. The remaining papers (478; 18%) were found
to be insufficiently related to malaria. The assembly of
references by country and subjects is shown in Figure 1.
To visualize general trends in peer reviewed publica-
tions, the number of malaria-related publications was
graphed and compared with overall biomedical publica-
tions over time (Figure 2). Over the 20-year study period,
the number of malaria-related publications rose 2.1 fold in
a linear fashion (linear trendline with r
2 =0 . 6 6 ) ,f r o m6 4
per year in 1990 to 136 per year in 2009. In the first dec-
ade of analysis 980 malaria-related publications were
identified, increasing to 1,242 during the following decade.
The proportion of papers reporting original data remained
relatively stable throughout the two decades at around
85%. Over the same period the number of biomedical pub-
lications relating to the target countries increased expo-
nentially (exponential trendline with r
2 = 0.95). The total
number of biomedical publications increased from 40,567
in the decade from 1990 through 1999 to 113,714 in the
decade from 2000 through 2009. The percentage of
malaria-related publications was nearly 3% (111/3,741) of
all biomedical publications in 1992 and decreased yearly
to less than 1% (118/12,171) by 2005, staying below 1%
thereafter (p < 0.001; Figure 3).
Publication output by country
Thailand had the highest output of malaria-related
papers (n = 1,211), followed by China (n = 609) and
Indonesia (n = 346). The output of malaria-related pub-
lications for Thailand, China, Indonesia, South Korea
and North Korea increased steadily (Figure 4). Following
the re-emergence of vivax malaria in 1993, North and
South Korea experienced the greatest relative increase in
publications from the first decade to the second (512%
and 422% respectively). Although the Solomon Islands
and Vanuatu had some of the lowest absolute numbers
of publications, they had the highest number of publica-
tions per capita (1.3 and 2.5 papers/1000 population).
Only two malaria-related papers during the 20-year per-
iod were associated with Bhutan [7,8]. There was a weak
correlation between the size of the population at risk of
malaria in a country and the numbers of papers on
malaria-related to the country (r
2 = 0.13). There was no
correlation between the GDP per capita, human devel-
opment index, health expenditure per capita and the
number of publications from a country.
Publication output by subject of publication
Publications were categorized into 10 subjects and
charted for the first and second decades of the study;
Figure 5. The epidemiology and control of malaria
accounted for 53% (1,183/2,222) of publications, fol-
lowed by drugs and drug resistance (47% 1,032/2,222; p
< 0.001)). Between the first and second decade there
was an increase in the proportion of articles on epide-
miology (1.15 fold; p < 0.001), entomology (1.24 fold; p
< 0.001), biology, molecular biology, pathophysiology
and diagnostics. In contrast there was a decrease in the
proportion of papers on immunology (0.67; p < 0.001),
clinical aspects of malaria (0.78 fold; p < 0.001), drugs
(0.95 fold; p = 0.3), and social sciences (0.91; p = 0.4).
Publication output by parasite species
The proportions of papers on P. vivax and P. falciparum
are shown in Figure 6. The proportion of all articles
Figure 1 Assembly of references.
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980) in the first decade to 56% (703/1242) in the second
(p < 0.001). In contrast, the proportion of articles asso-
ciated with P. vivax fluctuated between 22% and 38%,
with no major change from the first decade (30%, 296/
980) to the second (32%, 403/1242; p = 0.5). In only two
countries (North Korea 89%; 42/47 and South Korea
81%; 98/121) did the majority of malaria-related papers
deal with P. vivax and not with P. falciparum. Malaria-
related articles not explicitly relating to either species
increased from 22% (215/980) in the 1990’st oa na v e r -
age of 29% (361/1242) in the second decade (p < 0.001).
This group of publications mostly included papers on
molecular mechanisms, entomology and insecticides but
also the less frequently encountered human Plasmodium
sp. (ovale, malariae, knowlesi). Overall there were more
publications on P. falciparum compared with P. vivax
(Figure 7), with the total ratio being 1.95 P. falciparum
related articles for every P. vivax article (95%CI 1.89 to
2.00). The trend of P. falciparum articles being domi-
nant was apparent within each subject, with the excep-
tion of Social Sciences/Health Policy, where the
proportion of articles that did not relate specifically to
either Plasmodium species was higher than the propor-
tion that did. The majority of articles describing clinical
trials related to P. falciparum (85%; 260/307). But the
proportion of publications describing clinical trials relat-
ing to P. falciparum decreased steadily over the two
decades from 89% (62/70) between 1990 and 1995 to
81% (52/64) between 2005 and 2009 (p = 0.2) In con-
trast the percentage of publications describing clinical
studies relating to P. vivax or neither species remained
stable.
Discussion
Malaria related publications from 11 Asian Pacific coun-
tries committed to malaria elimination increased in a
linear fashion over the last two decades, doubling
between 1990 and 2009. In contrast the overall
Figure 2 The yearly number of malaria-related and all biomedical publications other than malaria from the 11 target countries, 1990
to 2009.
Figure 3 The percentage of malaria-related out of total
biomedical papers by year of publication.
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growth has largely been driven by China, which
increased its research output dramatically over the study
period. Funding for global malaria research has
increased substantially during the study period [9], yet
this is not reflected in the number of malaria-related
publications in APMEN countries. Over two decades,
there has been a three-fold reduction in the proportion
publications from the APMEN countries related to
malaria; currently less than one percent of biomedical
research is related to malaria. The reasons for this are
likely to be complex. Potential explanations include the
perceived decreased importance of malaria as its burden
in the APMEN countries falls with successful control
efforts. Simultaneously other areas of medical research,
such as cancer have been growing rapidly with the chan-
ging economy and demography. Whilst the funding for
malaria has increased in absolute terms, the funding for
other medical disciplines has grown even faster and is
now out-competing malaria research.
The research output per capita varied considerably
between countries. Surprisingly no significant correla-
tion could be detected between population at risk, GDP
per capita, human development index, health expendi-
ture per capita and the number of publications per
capita. Other local factors are likely to play an important
role in productivity. In Thailand for instance, one
research unit produced over 800 publications on malaria
over the last 20 years and has thus ensured the promi-
nence of Thailand in terms of publication outputs. The
proportion of research output specifically related to P.
falciparum decreased whereas the proportion of articles
relating to P. vivax remained relatively stable. This find-
ing may reflect a healthy correction of research priorities
Figure 4 The number of malaria-related articles in each
country per 5 year period.
Figure 5 Percentage of malaria-related articles by topic, 1990-
1999 and 2000-2009.
Figure 6 Comparison of the yearly percentage of articles on
Plasmodium vivax (PV) and falciparum (PF), 1990 to 2009 (with
trendlines).
Figure 7 Percentage of articles relating to Plasmodium vivax
(Pv), falciparum (Pf) or both species by country*. *ROK =
Republic of Korea, DRRK = Democratic People’s Republic of Korea.
Bhutan provided 2 data points and is not shown.
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morbidity in the APMEN countries.
The greatest number of articles relate to the subjects
of epidemiology and control, which reassuringly suggests
that controlling and monitoring the spread of malaria
remains a key priority. In contrast, the number of publi-
cations related to clinical trials is steadily decreasing,
perhaps reflecting a global policy change to artemisinin
combination therapy and the relative low priority given
to drug monitoring. This development may be short
sighted given the invariable emergence and spread of
drug resistant strains of Plasmodia [10-12].
The study has potential limitations in selection bias
and misclassification. Research publications are not
always an accurate mirror of research activities. Highly
relevant operative research may not be published but
are of great value for programmes. Furthermore the
extent to which an individual country is associated with
a particular publication may vary widely. Publications
that did not clearly distinguish whether the paper was
from South Korea, North Korea or both, were attributed
to both Koreas. This may have resulted in an inflated
number of papers attributed to North Korea because
there were only a small number of articles specifically
relating to North Korea compared to those relating to
South Korea. Also, assigning a paper to one country or
subject is inappropriate when multiple countries or sub-
jects are involved. Hence search algorithms targeting the
title, keywords and abstract were used to identify and
assign papers to multiple countries and subjects. This
approach was found accurate in spot checks. Compared
to manually extracting data from the text, using compu-
ter algorithms improves reproducibility. Also this meth-
odology can be rapidly applied and replicated to
maintain ongoing surveillance of temporal trends in
publication outputs. Lastly, papers that did not mention
as p e c i f i cPlasmodium species could not be assigned to
either P. vivax or P. falciparum.
Despite the challenges, 79 countries eliminated
malaria between 1945 and 2010. Of the remaining 99
endemic countries, about one third have reduced the
burden of malaria to low levels, and are now working
towards malaria elimination [13]. The methods required
for the elimination of malaria in the 20
th century may
no longer be feasible or appropriate in the 21
st Century.
The social structures of the last century have been
transformed. No longer can divisions of health care
workers be commandeered in a top down approach.
Parasite and vector resistance has rendered many insec-
ticides and antimalarial drugs useless. There is an urgent
need for basic research to discover safe and effective
interventions to prevent and cure all forms of malaria.
There is also an urgent need for operational research to
assist program managers in the optimization, scaling up,
and monitoring of interventions. Further work is needed
to identify funding, prioritize research topics, strengthen
capacity in endemic countries, and facilitate multi-coun-
try and institution collaborations such as APMEN, that
have the potential to evaluate new interventions across a
range of endemic environments.
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